Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study.
about
Statin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP?The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicityWomen and Ischemic Heart Disease: Recognition, Diagnosis and ManagementGenetic variants associated with VLDL, LDL and HDL particle size differ with race/ethnicityRelation of plasma midregional proatrial natriuretic peptide to target organ damage in adults with systemic hypertension.Recent development of ischaemic heart disease in sex difference.Bioactive oat β-glucan reduces LDL cholesterol in Caucasians and non-CaucasiansCholesterol treatment with statins: who is left out and who makes it to goal?Application of machine learning algorithms to predict coronary artery calcification with a sibship-based design.The heart truth professional education campaign on women and heart disease: needs assessment and evaluation results.A retrospective cohort study of the potency of lipid-lowering therapy and race-gender differences in LDL cholesterol control.Managing mixed dyslipidemia in special populations.Modification of fatty acids composition in erythrocytes lipids in arterial hypertension associated with dyslipidemiaClustering of Major Cardiovascular Risk Factors and the Association with Unhealthy Lifestyles in the Chinese Adult Population.Trends in cardiovascular risk factor levels in the Minnesota Heart Survey (1980-2002) as compared with the National Health and Nutrition Examination Survey (1976-2002): A partial explanation for Minnesota's low cardiovascular disease mortality?Obstructive sleep apnea and cardiovascular disease: evidence and underlying mechanisms.Impact of dyslipidemia on cardiovascular risk stratification of hypertensive patients and association of lipid profile with other cardiovascular risk factors: results from the ICEBERG study.Comparing self-reported disease outcomes, diet, and lifestyles in a national cohort of black and white Seventh-day Adventists.Dyslipidemia patterns among Hispanics/Latinos of diverse background in the United StatesHigh Cholesterol Awareness, Treatment, and Control Among Hispanic/Latinos: Results From the Hispanic Community Health Study/Study of Latinos.Risk-Factor Profile and Comorbidities in 2398 Patients With Newly Diagnosed Hypertension From the Abuja Heart Study.Ethnic differences in low-density lipoprotein particle size in hypertensive adults.Age- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the SardiNIA StudyEffect of gender, caregiver, on cholesterol control and statin use for secondary prevention among hospitalized patients with coronary heart disease.Blood lipids, infection, and inflammatory markers in the Tsimane of Bolivia.Comprehensive cardiovascular risk management--what does it mean in practice?Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? The single pill of amlodipine/atorvastatinThe clinical implications and management of concomitant hypertension and dyslipidemia.Matrix gla protein gene polymorphism is associated with increased coronary artery calcification progressionPrevalence and treatment of isolated and concurrent hypertension and hypercholesterolaemia in the United Kingdom.Risk factor profile for chronic kidney disease is similar to risk factor profile for small artery disease.Methods for estimation of disparities in medication use in an observational cohort study: results from the Multi-Ethnic Study of Atherosclerosis.Associations of microalbuminuria with brain atrophy and white matter hyperintensities in hypertensive sibships.Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its componentsEfficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-Haemostatic markers are associated with measures of vascular disease in adults with hypertension.Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect.Association of soluble cell adhesion molecules with ankle-brachial index in a biethnic cohort of predominantly hypertensive individuals.Association of serum myeloperoxidase with the ankle-brachial index and peripheral arterial disease.Serum lipid profile and correlates in newly presenting Nigerians with arterial hypertension.
P2860
Q24602803-51222B95-D73E-4663-A689-9F1BB5BC90CFQ24681859-8A2B7CC9-1BB1-4DEA-9C95-4902CFA22540Q26740081-F5842FD4-5198-40E6-B783-EEA1DDDAFC91Q30414022-72232D7C-4D79-43C6-A34C-04A1B337B9F1Q30479094-776B174F-3396-47BF-9E74-6A64D7A8A600Q30482406-9EAED4F9-963E-4F9E-BCA4-EF4D3A62449AQ33390465-7A3687EA-1A95-4E85-98D7-1CC5567F86ACQ33541739-29993617-9A14-4DEC-9F26-3591FCB944AEQ33689552-2026C32A-66CE-4FA4-ADC9-16FF907164BDQ33829386-EDB30AA7-2D2F-44C2-AABD-DF501053A1A3Q34036014-EE163093-328D-4805-8B38-B755DAE494CBQ34073832-B33EE9E1-7019-48B9-8DE1-73CE205BCF1FQ34570451-AE857725-162D-4316-9C10-2639FDCDC990Q34805957-15101968-2FD4-43F1-A9F7-655D2A9C7018Q35017908-FE21F030-A02A-46D7-8D96-8D7DB2074B63Q35020967-5C56D757-416B-4E71-B17D-89DDB8193782Q35210500-F297AADA-F5F3-4FF9-B7D2-A154F72FE59EQ35955883-FB211A5D-ED95-4FFA-B54A-B831D8CDAEE0Q36002007-183847AD-0905-4AF1-8C59-C5B867CA98E6Q36168724-635AB5F9-EBE4-4245-BEF6-C099F2D442CCQ36195971-CC491C42-7550-4499-B095-B0B04472F28DQ36252520-4ED2624E-6684-4053-AD97-6D759967909DQ36317004-1AC5A3FB-41BF-46E4-BFE4-3CC3546BA12EQ36395239-9D601B55-F43F-44EB-AFB6-E9A3F1DF1010Q36509994-DCBAFC26-6CD8-4C52-B364-FB6720723D69Q36536165-21465420-6106-4E32-BDB1-C45DEE053F3FQ36536199-9A810AD8-9994-489A-840B-406DF7715932Q36589145-62F00B8C-AAEB-4CEB-B6D6-C28A85E8C7B9Q36651164-F90AECCB-1F90-4722-A4D5-3FB527681294Q36729200-347250C1-A306-4BB5-A68F-F910A4093DF7Q36836959-ED870144-D1BF-4B84-AB6C-AEE40E3A3A48Q36839491-47068974-C889-471C-A7C1-C240A087D763Q36857484-4D355642-1307-4119-9F06-3352164BABB0Q36897409-5311C198-C325-44F0-8722-938AC400FD8BQ37194141-A27E49FC-7576-4A6E-AD7A-94C4E96F1212Q37266804-E29A8B56-8FC5-4110-8332-947C939A5A99Q37326940-46B42EC2-E121-42EA-85B1-7338712904CEQ37364327-068F7082-10A6-47D0-8E13-F0243143E747Q37364334-CCBA1B17-701F-402A-828F-65BF97524C09Q37378540-45F699AC-5A7F-4B29-9DB6-82CA5830FE52
P2860
Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Ethnic and sex differences in ...... ive adults in the GENOA study.
@en
Ethnic and sex differences in ...... ive adults in the GENOA study.
@nl
type
label
Ethnic and sex differences in ...... ive adults in the GENOA study.
@en
Ethnic and sex differences in ...... ive adults in the GENOA study.
@nl
prefLabel
Ethnic and sex differences in ...... ive adults in the GENOA study.
@en
Ethnic and sex differences in ...... ive adults in the GENOA study.
@nl
P2093
P1476
Ethnic and sex differences in ...... ive adults in the GENOA study.
@en
P2093
C Andrew Brown
Jeffrey J Armon
John G O'Meara
Stephen T Turner
P304
P356
10.1001/ARCHINTE.164.12.1313
P407
P577
2004-06-01T00:00:00Z